For Use With Insulin to Improve Glucose Control. SAN DIEGO, March 16 /PRNewswire-FirstCall ... ( Nasdaq: AMLN) today announced that the U.S. Food and ... | SAN DIEGO, Aug. 28 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. ( Nasdaq: AMLN) will be presenting at the Thomas Weisel Healthcare Conference in ... | Amylin and Lilly Announce FDA Approval of BYETTA(TM) (Exenatide) Injection --A New First-in-Class Treatment for Patients with Type 2 Diabetes ... | CHICAGO, June 25, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Amylin ... These findings were presented at the 67th Annual Scientific Sessions of the ... | SAN DIEGO, April 30 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. ( Nasdaq: AMLN) today announced it has re-scheduled its presentation time at the ... | BYETTA also Showed Sustained Improvements in Blood Glucose Control and ... CHICAGO, June 23, 2007 /PRNewswire-FirstCall via COMTEX News Network/ -- Amylin ... | SAN DIEGO, March 30 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. ... The Company has granted to the underwriters an option to purchase up to 1,500, ... | FDA Approves BYETTA(R) (exenatide) Injection for Expanded Combination Use. 11/24/06. Amylin Pharmaceuticals to Present at Piper Jaffray Healthcare Conference. 11 ... | content is expressly prohibited without the prior written consent of EDGAR ... shall not be liable for any errors or delays in the content, or for any actions ... | | sitemap | sitemap html | qlweb | investors.amylin.com | kody pocztowe | 404design | hosting | biżuteria | srebro | nurkowanie | paintball | sennik | biblie online | katalog stron | praca | subaru impreza | | Słowniki On-line | System Zarządzania | Nieruchomości Wrocław | Programista PHP | Bhp

Results for: investors.amylin.com - Language: english

Language: english
EN DE FR ES PL
1.

Amylin - Investor Relations - Investors


10/23/08, Amylin Pharmaceuticals to Present at BIOCOM Investor Conference · Printer Friendly Version. 10/21/08, Amylin Pharmaceuticals Reports Third Quarter ...
2.

Amylin - Investor Relations - Press Release


"The findings are consistent with our internal discovery that amylin restores leptin responsiveness in diet-induced obese rats, and thus greatly increase ...
3.

amylin.com - Domain Profile | BoardReader


http://investors.amylin.com/phoenix.zhtml?c=101911&p=irol-newsArticle&ID=10, 1, 3, info · http://investors.amylin.com/phoenix.zhtml?c=101911&p=irol- ...
4.

PharmaLive: Amylin Pharmaceuticals to Present at BIOCOM Investor ...


SAN DIEGO, Oct. 23 /PRNewswire-FirstCall/ -- Amylin Pharmaceuticals, Inc. ( Nasdaq: AMLN) will be presenting at the BIOCOM Investor Conference in San Diego ...
5.

Amylin


Investor Relations News, SEC filings, presentation archives, stock information ... Amylin is dedicated to improving lives through the discovery, ...
6.

Amylin


Amylin to Webcast Investor Conference Call. Amylin Pharmaceuticals will webcast a conference call to discuss the BYETTA approval and commercialization plans ...
7.

Amylin Pharmaceuticals to Present at Nasdaq 20th Investor Program


San Diego/Orange County Technology News. Largest Daily Tech & BioTech News Source since 1996. We cover Biotechnology Daily. 3000 + southern California tech ...
8.

Amylin Pharmaceuticals Inc - SWOT Analysis - market research report


Amylin Pharmaceuticals Inc - SWOT Analysis Datamonitor's Amylin ... compared to a net loss of $218.9 in 2006. http://investors.amylin.com/phoenix.zhtml?c= ...
9.

Amylin - Investor Relations - Press Release


Amylin Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving lives through the discovery, development and commercialization of ...
10.

Amylin Pharmaceuticals to Present at BIOCOM Investor Conference ...


Amylin Pharmaceuticals to Present at BIOCOM Investor Conference from PR Newswire in Business provided free by Find Articles.